Acquired Methemoglobinemia in the Surgical Intensive Care Unit.

Am Surg

Department of Surgery, Spartanburg Regional Healthcare System, Spartanburg, SC, USA.

Published: September 2023

Acquired methemoglobinemia is a potentially lethal medical condition caused by exposure to oxidizing xenobiotics, including antibiotics such as dapsone and inhaled anesthetics such as benzocaine. In this case report, we describe two presentations of acquired methemoglobinemia which presented to our surgical intensive care unit within one month. This highlights the potential connection between an emergent surgery or procedure and the development of methemoglobinemia in an environment where it is presumed that this condition would be extremely rare. High clinical suspicion for methemoglobinemia is warranted if the patient develops cyanosis or a decreased oxygen saturation unresponsive to supplemental oxygen when another etiology is not identifiable. If methemoglobinemia is suspected, a direct measurement of blood methemoglobin levels can be obtained to confirm the diagnosis. Prompt treatment with intravenous methylene blue is highly effective.

Download full-text PDF

Source
http://dx.doi.org/10.1177/00031348231173959DOI Listing

Publication Analysis

Top Keywords

acquired methemoglobinemia
12
surgical intensive
8
intensive care
8
care unit
8
methemoglobinemia
5
methemoglobinemia surgical
4
unit acquired
4
methemoglobinemia lethal
4
lethal medical
4
medical condition
4

Similar Publications

Methemoglobinemia (MetHb) is a life-threatening condition that reduces the oxygen-carrying ability of hemoglobin. Acquired methemoglobinemia usually results from exposure to specific oxidizing agents. Symptoms and complications depend on the MetHb level, which can sometimes be fatal.

View Article and Find Full Text PDF

Methemoglobinemia is a rare but potentially life-threatening condition in which hemoglobin is oxidized, impairing the oxygen-carrying capacity. While congenital forms exist, acquired methemoglobinemia can occur in perioperative settings, especially following exposure to oxidizing agents such as dyes used in sentinel lymph node biopsy (SLNB). Patent Blue V, a synthetic aniline dye commonly used for SLNB, has been associated with rare but serious adverse effects, including methemoglobinemia.

View Article and Find Full Text PDF
Article Synopsis
  • Methaemoglobinaemia is a rare condition that can cause cyanosis, often linked to anaesthetic agents, but this case series highlights three instances related to acute gastroenteritis from formula feeds in newborns.
  • The infants presented with symptoms of hypoxia, metabolic acidosis, and diarrhea, which can complicate the usual diagnosis, emphasizing the need for awareness of this condition.
  • Rapid identification and treatment with methylene blue and fluid therapy were crucial, leading to successful recovery and discharge on exclusive breast feeds.
View Article and Find Full Text PDF

Life-Threatening Methaemoglobinaemia Secondary to Cetrimide.

Eur J Case Rep Intern Med

September 2024

Department of Medicine, Division of Pulmonary and Critical Care Medicine, Mount Lebanon Hospital Balamand University Medical Center, Beirut, Lebanon.

Article Synopsis
  • * The condition is characterized by oxidized hemoglobin (ferric state), leading to symptoms like low blood oxygen levels, hypoxia, and distinct chocolate-colored blood.
  • * A case study highlights how cetrimide, used in abdominal surgeries for hydatid cysts, can trigger severe methaemoglobinaemia, which often goes undiagnosed but has a high risk of mortality.
View Article and Find Full Text PDF

Maternal NO exposure and fetal growth restriction: Hypoxia transmission and lncRNAs-proinflammation-mediated abnormal hematopoiesis.

Proc Natl Acad Sci U S A

October 2024

Department of Environment Science, College of Environment and Resource, Research Center of Environment and Health, Shanxi Key Laboratory of Coal-based Emerging Pollutant Identification and Risk Control, Shanxi University, Taiyuan, Shanxi 030006, People's Republic of China.

Article Synopsis
  • Epidemiological studies indicate that air pollution, specifically nitrogen dioxide (NO), is linked to fetal growth restriction (FGR), particularly when exposure occurs during the second trimester.
  • A retrospective analysis of nearly 29,000 newborns showed a positive correlation between maternal NO exposure and the risk of having small-for-gestational-age babies, with a specific odds ratio calculated.
  • Animal studies further confirmed that maternal NO inhalation affects embryonic development and the hematopoietic system, with findings suggesting that this exposure leads to placental hypoxia, thereby activating certain biological pathways that contribute to FGR.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!